KK
GILD icon

KLP Kapitalforvaltning’s Gilead Sciences GILD Stock Holding History

KLP Kapitalforvaltning’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$96.3M Buy
762,308
+43,900
+6% +$5.78M 0.31% 55
2026
Q1 		$100M Sell
718,408
-72,400
-9% -$10.1M 0.39% 40
2025
Q4 		$97.1M Sell
790,808
-5,500
-0.7% -$668K 0.37% 41
2025
Q3 		$88.4M Buy
796,308
+100
+0% +$11.4K 0.35% 44
2025
Q2 		$88.3M Buy
796,208
+20,100
+3% +$2.14M 0.38% 41
2025
Q1 		$87M Buy
776,108
+21,500
+3% +$2.22M 0.43% 33
2024
Q4 		$69.7M Buy
+754,608
New +$67.9M 0.33% 47

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

KLP Kapitalforvaltning's GILD Position: Q2 2026 in Review

KLP Kapitalforvaltning increased its Gilead Sciences (GILD) stake by 6.1% in Q2 2026, buying an estimated $5.78M and bringing the position to 762,308 shares worth $96.3M. The position accounts for 0.31% of the portfolio, ranked #55.

KLP Kapitalforvaltning first reported a position in GILD in Q4 2024 and has held it in 7 quarters since. The position peaked at $100M in Q1 2026. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • KLP Kapitalforvaltning held 762,308 shares of Gilead Sciences worth $96.3M as of Q2 2026.
  • KLP Kapitalforvaltning bought 43,900 Gilead Sciences shares in Q2 2026, an estimated $5.78M.
  • Gilead Sciences made up 0.31% of KLP Kapitalforvaltning's portfolio in Q2 2026, its #55 holding.
  • KLP Kapitalforvaltning first reported a position in Gilead Sciences in Q4 2024 and has held it in 7 quarters since.
  • KLP Kapitalforvaltning's Gilead Sciences position peaked at $100M in Q1 2026.
  • 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q2 2026, filed 12 Aug 2026.